On the Forefront: A new tool that detects ivermectin and other drug sensitivities in dogs - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


On the Forefront: A new tool that detects ivermectin and other drug sensitivities in dogs



1. Pulliam, J.D. et al.: Investigating ivermectin toxicity in Collies. Vet. Med. 80 (6):33-40; 1985.

2. Paul, A.J. et al.: Clinical observations in collies given ivermectin orally. AJVR 48 (4):684-685; 1987.

3. Heit, J.E. et al.: Clinical management of ivermectin overdose in a collie dog. Companion Anim. Pract. 19:3-7; 1989.

4. Stavrovskaya, A.A.: Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry (Mosc.) 65 (1):95-106; 2000.

5. Dicato, M. et al.: Multidrug resistance: Molecular and clinical aspects. Cytokines Cell Mol. Ther. 3 (2):91-99; 1997.

6. Sun, J. et al.: Multidrug resistance P-glycoprotein: Crucial significance in drug disposition and interaction. Med. Sci. Monit. 10 (1):RA5-RA14; 2004.

7. Schinkel, A.H. et al.: P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97 (11):2517-2524; 1996.

8. Schinkel, A.H. et al.: Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96 (4):1698-1705; 1995.

9. Mealey, K.L. et al.: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11 (8):727-733; 2001.

10. Mealey, K.L. et al.: Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States. AJVR 63 (4):479-481; 2002.

11. Fromm, M.F.: P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int. J. Clin. Pharmacol. Ther. 38 (2):69-74; 2000.

12. Sartor, L.L. et al.: Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. J. Vet. Intern. Med. 18 (1):117-118; 2004.

13. Mealey, K.L. et al.: Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. JAVMA 223 (10):1453-1455; 2003.

14. Tranquilli, W.J. et al.: Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies. AJVR 52 (7):1170-1172; 1991.

15. Plumb, D.C.: Veterinary Drug Handbook, 4th Ed. Iowa State University Press, Ames, 2002; pp 734-735, 572-574, 557-558.


Click here